Praxis Precision Medicines, Inc.
PRAX • NASDAQ
Praxis Precision Medicines, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Marcio Silva De'Souza, with a market cap of $8.1B.
CEOMarcio Silva De'Souza
Next Earnings
Upcoming earnings announcement for Praxis Precision Medicines, Inc.
Date
Friday, May 1, 2026 (in a month)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$3.67
Earnings History
Past 12 earnings reports for Praxis Precision Medicines, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 19, 2026 | Q4 2025 | -$3.50Est: -$3.08 | -13.6% | -Est: $256.1K | -100.0% |  10-K |
| Nov 5, 2025 | Q3 2025 | -$3.36Est: -$3.47 | +3.2% | -Est: $59.4K | -100.0% | 10-Q |
| Aug 4, 2025 | Q2 2025 | -$3.31Est: -$3.37 | +1.8% | -Est: $210.3K | -100.0% | 10-Q |
| May 2, 2025 | Q1 2025 | -$3.29Est: -$3.20 | -2.8% | -Est: $183.1K | -100.0% | 10-Q |
| Feb 28, 2025 | Q4 2024 | -$2.94Est: -$2.96 | +0.7% | $7.5MEst: $480.0K | +1454.8% | 10-K |
| Nov 6, 2024 | Q3 2024 | -$2.75Est: -$1.99 | -38.2% | $302.0KEst: $300.0K | +0.7% | 10-Q |
| Aug 13, 2024 | Q2 2024 | -$1.74Est: -$2.31 | +24.7% | $357.0KEst: $830.0K | -57.0% | 10-Q |
| May 13, 2024 | Q1 2024 | -$2.84Est: -$2.08 | -36.5% | $431.0KEst: $1.6M | -73.4% | 10-Q |
| Mar 5, 2024 | Q4 2023 | -$2.97Est: -$3.13 | +5.1% | $515.0KEst: $50.0K | +930.0% | 10-K |
| Nov 7, 2023 | Q3 2023 | -$2.70Est: -$5.25 | +48.6% | $468.0K | — | — |
| Aug 9, 2023 | Q2 2023 | -$7.35Est: -$9.75 | +24.6% | - | — | 10-Q |
| May 11, 2023 | Q1 2023 | -$10.65Est: -$12.00 | +11.2% | - | — | — |